Covidien to Buy VNUS Medical Technologies
Forbes reports that medical device maker Covidien is buying VNUS Technologies for $440 million in cash.
Articles by bjohnson56
FDA Approves Fanapt for Schizophrenia Patients
Maryland-based Vanda Pharmaceuticals announced that the U.S. Food and Drug Administration has approved Fanapt (otherwise known as iloperidone) for the acute treatment of adult patients with schizophrenia.
Focal Drug Delivery Helps Deadly Brain Tumor, Study Shows
A method of delivering chemotherapy drugs into a deadly type of brain tumor extended the lives of patients in early clinical trials.
Clarient Launches New Breast Cancer Test
Clarient is launching a new breast cancer test that helps physicians assess the probability of a patient’s cancer returning.
Studies Back Gen-Probe’s Prostate Cancer Test
Eight studies presented this week at the American Urological Association Annual Meeting suggest that Gen-Probe’s investigational test for the prostate cancer gene PCA3 may address some of the major challenges faced by urologists when diagnosing the disease.
Speakers Announced for MDMA Annual Meeting
The Medical Device Manufacturers Association (MDMA) 2009 Annual Meeting will take place at the Park Hyatt Washington in Washington, D.C. from June 1-3, 2009. The […]
Provenge Extends Life of Prostate Cancer Patients, Study Finds
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.
Microline PENTAX Acquires Starion Instruments
Two strong players in the surgical-instrument field have joined forces. Microline PENTAX, a leading manufacturer of reposable surgical instruments for laparoscopic procedures, has acquired California-based Starion Instruments, a developer of instruments to arrest bleeding during surgical procedures.
Isto Gets Go-Ahead for Clinical Study of NuQu
ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative disc disease.
Thermo Fisher to Acquire Biolab
Thermo Fisher Scientific, a developer of analytical instruments and research products, has announced plans to acquire Biolab for $120 million.